If they had any foresight at all they would have financed all they needed to get through this when the stock was at $12. They fully underestimated what small biotechs go through. If they were at all capable they would have known this.
No one in management had enough experience to prepare for what was about to happen. And that alone is why they should not be paid the big bucks. They have a great product but didn't know what to do with it. Hence all the silence when things started to go south.
Have you read any of the PR's prior to their silence? How about the approval in Switzerland? Go through the PR's on their website. How many of them actually deal with any science?
I have over 400k shares. I may be long, but I don't have to be happy about what has went on here and just be all rah rah rah...